Breaks Categories: Stock Spotlights

TuesdayFeb 13, 2018 3:08 pm

NetworkNewsBreaks – Medical Cannabis Payment Solutions (REFG) Helps Cannabis Distributors Remain Compliant with Green Platform

Cannabis-focused financial services company Medical Cannabis Payment Solutions (OTC: REFG) recently launched Green, a platform with full merchant account functionality. Green enables marijuana dispensaries immediate access to funds while remaining compliant with all Financial Crimes Enforcement Network (FinCEN) laws. An article discussing the platform reads: “Medical Cannabis Payment Solutions (OTC: REFG) provides the industry with fully secure, state-of-the-art financial services that are simple to set up and easy to use. In January, the company launched Green, a platform with full merchant account functionality. Cash-only operations are now a thing of the past. This comprehensive card processing operation allows for online…

Continue Reading

TuesdayFeb 13, 2018 2:56 pm

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Aims to Halt Cancerous Tumor Progression Utilizing Scorpion Venom Product

Early-stage life sciences company PreveCeutical Medical’s (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) novel “scorpion venom” product builds on popular Cuban cancer-fighting therapy. An article discussing the company’s innovative solutions reads: “The scorpion venom product builds on discoveries in Cuba and the surrounding Caribbean nations advancing the popular belief that the venom inhibits the growth of cancer cells. PreveCeutical’s product, CELLB9Ò dietary supplement, utilizes select peptides from the blue scorpion (which is actually red, with a blue tail) to boost the user’s immune system, and the company is advancing its research into producing a “nature identical” scorpion peptide solution that it…

Continue Reading

TuesdayFeb 13, 2018 1:06 pm

NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Secures Laboratory Partner for Clinical Studies of MSN-2 Medical Device

Science-based biotechnology company Earth Science Tech, Inc. (OTC: ETST) recently signed an agreement with a private laboratory for clinical studies related to its MSN-2 medical device. “We are on the cusp of making tremendous progress in our clinical trial efforts,” Dr. Michel Aubé, CEO and CSO of ETST, stated in a news release. An article discussing the agreement reads: “ETST now has the laboratory partner needed to support the company’s research and development efforts, along with the commercialization of its MSN-2 medical device, which has been specifically developed to support women’s health and the related molecular diagnostics to which women…

Continue Reading

FridayFeb 09, 2018 1:50 pm

NetworkNewsBreaks – Skinvisible, Inc. (SKVI) Takes Aim at PTSD-related Suicides through Quoin Partnership

Skinvisible, Inc. (OTCQB: SKVI) is working toward developing a transdermal treatment for post-traumatic stress disorder through its patented Invisicare® technology that could address the devastating number of veteran suicides that occur throughout the country. The company’s proposed merger with Quoin Pharmaceuticals would direct Skinvisible’s drug delivery capacity to boost the bioavailability of Quoin’s promising pharmaceuticals. An article discussing this reads: “Skinvisible, through its wholly owned subsidiary Skinvisible Pharmaceuticals, Inc., has already developed, licensed and sold multiple dermatology and health care products, as well as various medical treatments, using its patented Invisicare® technology. … Quoin’s two lead products are targeting crises…

Continue Reading

FridayFeb 09, 2018 1:22 pm

NetworkNewsBreaks – Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) Exploring Lithium Extraction Potential of Arkansas Brine Fields

Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) is exploring the potential of extracting battery-grade lithium for the modern tech fuel market from brine fields in the large production-ready Smackover Formation that stretches across Southern Arkansas and neighboring states. The demand for lithium is expected to skyrocket over the next eight years, particularly in conjunction with growing demand for electric vehicles. An article discussing this reads: “Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTCQX: STLHF) actively seeks to reduce political, permitting and technology risks, all while positioning itself as a leader in the production of lithium. The company works…

Continue Reading

FridayFeb 09, 2018 12:50 pm

NetworkNewsBreaks – Pivot Pharmaceuticals Inc. (PVOTF) Working on Delivery of Smokeless Cannabinoid Options

Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) is focused on providing the health care marketplace with nutraceutical and pharmaceutical options for treating certain unmet needs. That extends to the medical cannabis industry, where the lack of a robust smokeless delivery system has troubled cannabinoid producers. An article discussing this reads: "Transdermal delivery provides the benefit of enabling patients to access a steady stream of medication over a prolonged period with fewer side effects. Pivot Pharmaceutical’s newly created subsidiary, Pivot Green Stream Health Solutions Inc. (“Pivot Green Stream”), will focus on improving the bioavailability of cannabinoid-based and pharmaceuticals. BiPhasix™ has been tested in…

Continue Reading

FridayFeb 09, 2018 11:47 am

NetworkNewsBreaks – PotNetwork Holding Inc. (POTN) Sales Drive Optimistic Share Price Target

PotNetwork Holding Inc. (OTC: POTN) has reported favorable monthly sales data and a strong quarterly filing in its drive to produce high-grade CBD for use in oils, tinctures, edibles and vape liquids. This performance is, in turn, generating forecasts for a heightened share price. The holding company for a number of subsidiaries in the hemp-extract medical cannabis industry, PotNetwork has been named 'One of Five Notable CBD Revolution Industry Leaders' by media outlet The Huffington Post. An article discussing this reads: "A recent comprehensive report by SeeThruEquity highlighting PotNetwork Holding Inc. (OTC: POTN) and its subsidiary, Diamond CBD, projected a…

Continue Reading

FridayFeb 09, 2018 9:37 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. Secures Financing Boost for Cannabis Facilities Expansion

Ultra-low cost organic cannabis producer The Green Organic Dutchman Holdings Ltd., also known as TGOD, has benefited from strategic investments by marijuana industry powerhouse Aurora Cannabis Inc. (OTCQX: ACBFF) (TSX: ACB) and other private placement financing, with its total financing climbing to $160 million. The Aurora investment in TGOD is accompanied by a supply agreement providing Aurora the right to purchase up to 20 percent of TGOD’s annual production of organic cannabis, and TGOD will receive additional services from Aurora and its subsidiary, Aurora Larssen Projects Inc. ("ALPS"). An article discussing this reads: “The investment fully funds the expansion of…

Continue Reading

FridayFeb 09, 2018 9:20 am

NetworkNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Advancing Work on Novel Delivery for Cannabinoid Therapies

A partnership between health sciences company PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and Australia’s UniQuest Pty Limited aimed at furthering research and development of a soluble gel is working toward a novel means of delivering cannabinoids to the central nervous system directly from the nasal cavity in order to treat pain, inflammation, seizures and neurological disorders. The partnership is taking advantage of the growing legalization of medical marijuana throughout the world amid increasing evidence of cannabinoids’ benefits. An article discussing this reads: “The global nasal drug delivery technology market is projected to reach $64 billion by 2021, expanding…

Continue Reading

TuesdayFeb 06, 2018 11:09 am

NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enters Agreement to Create Cannabis-infused Edibles Utilizing DehydraTECH™ Delivery Technology

Lexaria Bioscience (CSE: LXX) (OTCQB: LXRP) recently entered an agreement with a cannabis-infused edibles manufacturer, Cannfections Group Inc. The agreement is expected to generate new cannabis-based edible products using Lexaria’s patented DehydraTECH™ delivery technology. An article discussing the agreement reads: “On January 25, 2018, Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) announced that it had entered into a seven-year agreement with Cannfections Group Inc. to provide its patented DehydraTECH™ technology for the development of a new range of cannabis-infused chocolates and gummies (http://nnw.fm/9DgLc). Cannfections is a new company, established by one of Canada’s leading chocolate manufacturers with over 85 years…

Continue Reading